Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

John Tesh Talks Of Battling Prostate Cancer That Doesn’t Produce PSA

John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...

PSA increases turnaround times due to high demand

PSA is increasing turnaround times for grading and authentication services due to high demand, the company announced Thursday. The grader is also changing when estimated turnaround times begin, with ...